Furosemide
- Product NDC
- 17224-178
- 11-digit product format
- 172240178
- Labeler code
- 17224
- Product ID
- 17224-178_f790f48e-79bb-4d43-e053-6294a90a2b29
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FUROSEMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Calvin Scott & Co., Inc.
- Application
- ANDA077293
- Marketing category
- ANDA
- Marketing start
- 2006-02-01
- Substance
- FUROSEMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FUROSEMIDE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7LXU5N7ZO5 |
| Rxcui | 310429 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17224-178-21 | Furosemide | 21 in 1 BOTTLE | TABLET | 21 | | 1 |
| 17224-178-30 | Furosemide | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17224-178 | FUROSEMIDE (FUROSEMIDE) TABLET [CALVIN SCOTT & CO., INC.] | 1 | Current NDC, 2 package rows | 20230324_43be0231-0d88-4a21-b2ab-793155cbddb2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 17224-178-21 | 17224017821 | 21 TABLET in 1 BOTTLE (17224-178-21) | 21 tablet | 2016-05-15 | No | No | Current |
| 17224-178-30 | 17224017830 | 30 TABLET in 1 BOTTLE (17224-178-30) | 30 tablet | 2016-05-15 | No | No | Current |